Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Rudolph M. Navari

Indiana University School of Medicine South Bend

1234 North Notre Dame Avenue

South Bend

IN 46617-1404

USA

[email]@nd.edu

Name/email consistency: high

[Claim this account]

Affiliations

Indiana University School of Medicine South Bend, 1234 North Notre Dame Avenue, South Bend, IN 46617-1404, USA. 2006 - 2010
Department of Medicine, Indiana University School of Medicine South Bend, USA. 2007 - 2010
University of Notre Dame, Walther Cancer Research Center, South Bend, IN 46617, USA. 2009
Walther Cancer Research Center, University of Notre Dame, Notre Dame, IN 46556, USA. 2003 - 2009
Notre Dame Cancer Institute, University of Notre Dame, 224 Raclin-Carmichael Hall, Notre Dame, USA. 2007

References

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer. Navari, R.M. Future. Oncol (2010) [Pubmed]
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Navari, R.M., Brenner, M.C. Support. Care. Cancer (2010) [Pubmed]
Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist. Navari, R.M. Expert. Opin. Drug. Metab. Toxicol (2009) [Pubmed]
Antiemetic control: toward a new standard of care for emetogenic chemotherapy. Navari, R.M. Expert. Opin. Pharmacother (2009) [Pubmed]
Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments. Navari, R.M. Drugs (2009) [Pubmed]
Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Navari, R.M., Brenner, M.C., Wilson, M.N. Breast Cancer Res. Treat. (2008) [Pubmed]
Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Navari, R.M. Expert. Rev. Anticancer. Ther (2008) [Pubmed]
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Navari, R.M., Einhorn, L.H., Loehrer, P.J., Passik, S.D., Vinson, J., McClean, J., Chowhan, N., Hanna, N.H., Johnson, C.S. Support. Care. Cancer (2007) [Pubmed]
Prevention of emesis from multiple-day and high-dose chemotherapy regimens. Navari, R.M. J. Natl. Compr. Canc. Netw (2007) [Pubmed]
Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Navari, R.M. Expert. Opin. Investig. Drugs (2007) [Pubmed]
Emerging drugs for chemotherapy-induced emesis. Navari, R.M., Province, P.S. Expert. Opin. Emerg. Drugs (2006) [Pubmed]
Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist. Navari, R.M. Future. Oncology. (london,. England) (2006) [Pubmed]
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Navari, R.M., Einhorn, L.H., Passik, S.D., Loehrer, P.J., Johnson, C., Mayer, M.L., McClean, J., Vinson, J., Pletcher, W. Support. Care. Cancer (2005) [Pubmed]
Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. Navari, R.M. Expert. Rev. Anticancer. Ther (2004) [Pubmed]
Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials. Navari, R.M. Cancer Invest. (2004) [Pubmed]
Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists. Navari, R.M., Koeller, J.M. Ann. Pharmacother (2003) [Pubmed]
Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents. Navari, R.M. J. Support. Oncol (2003) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.